ECG-Based Fluid Responsiveness Prediction System

The patent replaces invasive mechanical monitoring systems (arterial lines, stroke volume variation monitors) with a non-invasive ECG-based electrical signal analysis system. The method uses standard ECG leads to detect electrical cardiac signals and processes them through algorithms that analyze heart rate variability and electrical characteristics to predict fluid responsiveness without requiring invasive catheters or complex mechanical sensors.

The patent extracts the essential predictive information from the ECG signal itself, separating the prediction function from the invasive monitoring infrastructure. By isolating the key electrical cardiac parameters (heart rate, RR interval variability, electrical axis) from the ECG waveform, the system achieves fluid responsiveness prediction using only standard ECG equipment already present in most clinical settings, eliminating the need for additional invasive devices.

The patent merges multiple ECG-derived parameters into a unified analysis framework that simultaneously evaluates heart rate, RR interval variability, electrical axis orientation, and waveform characteristics. This integrated approach allows the system to capture the interplay between different physiological variables (autonomic nervous system activity, respiratory variations, cardiac mechanics) that individually cannot predict fluid responsiveness accurately, thereby improving precision while maintaining relative simplicity.

The patent creates a universal ECG-based prediction system that serves multiple functions: it analyzes electrical cardiac activity, detects respiratory variations, evaluates autonomic tone, and predicts fluid responsiveness. By making the ECG signal multi-functional for these diverse assessment purposes, the system achieves high measurement precision without requiring separate specialized monitors for each parameter, thus maintaining operational simplicity.